Niu Jianqin, Li Tao, Yi Chenju, Huang Nanxin, Koulakoff Annette, Weng Chuanhuang, Li Chengren, Zhao Cong-Jian, Giaume Christian, Xiao Lan
Department of Histology and Embryology, Faculty of Basic Medicine, Chongqing Key Laboratory of Neurobiology, Third Military Medical University, Chongqing 400038, China.
Collège de France, Center for Interdisciplinary Research in Biology (CIRB)/Institut National de la Santé et de la Recherche Médicale U1050, Paris 75231, Cedex 05, France.
J Cell Sci. 2016 May 1;129(9):1902-14. doi: 10.1242/jcs.178731. Epub 2016 Mar 22.
Oligodendrocyte precursor cells (OPCs) undergo a series of energy-consuming developmental events; however, the uptake and trafficking pathways for their energy metabolites remain unknown. In the present study, we found that 2-NBDG, a fluorescent glucose analog, can be delivered between astrocytes and oligodendrocytes through connexin-based gap junction channels but cannot be transferred between astrocytes and OPCs. Instead, connexin hemichannel-mediated glucose uptake supports OPC proliferation, and ethidium bromide uptake or increase of 2-NBDG uptake rate is correlated with intracellular Ca(2+) elevation in OPCs, indicating a Ca(2+)-dependent activation of connexin hemichannels. Interestingly, deletion of connexin 43 (Cx43, also known as GJA1) in astrocytes inhibits OPC proliferation by decreasing matrix glucose levels without impacting on OPC hemichannel properties, a process that also occurs in corpus callosum from acute brain slices. Thus, dual functions of connexin-based channels contribute to glucose supply in oligodendroglial lineage, which might pave a new way for energy-metabolism-directed oligodendroglial-targeted therapies.
少突胶质前体细胞(OPCs)会经历一系列耗能的发育事件;然而,其能量代谢物的摄取和运输途径仍不清楚。在本研究中,我们发现荧光葡萄糖类似物2-NBDG可通过基于连接蛋白的缝隙连接通道在星形胶质细胞和少突胶质细胞之间传递,但不能在星形胶质细胞和OPCs之间转移。相反,连接蛋白半通道介导的葡萄糖摄取支持OPCs增殖,溴化乙锭摄取或2-NBDG摄取率的增加与OPCs细胞内Ca(2+)升高相关,表明连接蛋白半通道的Ca(2+)依赖性激活。有趣的是,星形胶质细胞中连接蛋白43(Cx43,也称为GJA1)的缺失通过降低基质葡萄糖水平抑制OPCs增殖,而不影响OPCs半通道特性,这一过程在急性脑片的胼胝体中也会发生。因此,基于连接蛋白的通道的双重功能有助于少突胶质谱系中的葡萄糖供应,这可能为能量代谢导向的少突胶质靶向治疗开辟一条新途径。